Evans to Host Press Conference to Release Report on the Soaring Prices of Diabetes Drugs in his District
On Wednesday, May 29 at 10 a.m., Congressman Dwight Evans (PA-03) will release a report on the prices of diabetes drugs for seniors and the uninsured in Pennsylvania’s 3rd Congressional District.
The report finds that the prices of diabetes medications — and insulin in particular — are far higher in the United States than they are overseas, in part because Medicare lacks the authority to negotiate directly with drug manufacturers. For example, the cost of a widely-used insulin for Medicare beneficiaries in Pennsylvania’s 3rd District could be reduced by up to 94 percent at Australian prices, 91 percent at British prices, and 89 percent at Canadian prices.
The press conference will include personal stories from constituents about their hardships in affording their vital diabetes medications.
WHO: Congressman Dwight Evans
Dr. Nissa Blocher, Einstein Hospital
Philadelphia residents impacted by cost of diabetes medications
WHAT: Press Conference to Release Report on the Soaring Prices of Diabetes Drugs
WHEN: Wednesday, May 29 at 10 a.m.
WHERE: Einstein Medical Center Philadelphia
5501 Old York Road
Philadelphia, PA 19141
Evans represents the 3rd Congressional District, which includes Northwest and West Philadelphia and parts of North, South, Southwest and Center City Philadelphia.
Media Contact: Ben Turner, Ben.Turner@mail.house.gov